|
|
 |
|
Viewing report
|
|
|
|
The US Bio-Chip Market for Pharmaceutical Drug Discovery: Technology, Strategic Alliance, Patent Dispute and Market Update, 2002
Fuji-Keizai USA, Inc., Pages: 194
This report is new market research about the technologies, opportunities and the market for biochips and systems that are being used for accelerating the research processes and capabilities of bio-pharmaceutical drug discovery.
This study has found that the total biochip market size in 2001 is about $740 million and may more than triple in revenues, to about $2.47 billion in 2006. The 5-year Cagr is 27.3%. This market includes biochip systems, Lab-on-a chip devices, microarrays, protein chips and other related technologies.
In particular, biochip technologies will continue to help pharma companies. Facing near term product pipeline challenges, Pharma companies have seen their R& D costs explode as their delivery of new drug products have declined. Many of their current high priced $billion -plus blockbuster drugs will reach their patent expirey dates by 2005-2006 and draw competition from generic drug makers. These companies have tried growing through M& As, but their growth has not increased. As a result, pharma companies have increasingly become a source of strong research and financial partners with many of the companies in the biotechnology industry. Pharma companies are motivated to become customers and partners of biochip companies because these companies have technologies that might help the big pharma companies become more productive and deliver more than one product, in a shortened time frame rather than in the current 10-15 year drug development process.
Accelerating the drug making process means turning to modern industrialization of R& D, using genomics and proteomics technologies, and other capabilities that bio-chip companies can provide. This report targets these important issues with interesting and useful findings. This study uses more than 46 figures and tables to illustrate the findings.
The wealth of data in the tables summarizes 90 alliance deals, over 375 patents, reviews recent patent disputes, includes categorized lists of microarray products, technologies and 75 web links.
Customers who bought this item also bought
Advances in Lab-on-Chip and Microfluidics Technologies for Drug Discovery and Clinical Diagnostics
Microarray Markets
Biochip Trends for Drug R&D and Diagnostics -- Companies, Equipment, Consumables, Software, Services and World Market
Biochip Trends for Drug R&D and Diagnostics – Companies, Equipment, Consumables, Software, Services and World Market
Emerging Technologies in Lab-on-a-Chip: Microarrays and Biochips (Technical Insights)
2007 The Worldwide Biochip & Equipment Market
2007 The Worldwide Biochip & Equipment Market
The US Biochip and Equipment Market and Business - 2003 Edition Technology Trends, Market and Business Trends, Sales, and Distribution
The Future of Array Technologies: Impact on Drug Discovery and Market Growth in DNA, Protein
Emerging Drug Discovery Technologies: Building competitive advantage through lab-on-a-chip, nanotechnology and RNAi
Worldwide Cell Based Screening & Analysis Market for Bio-Pharma Drug Discovery
U.S. Next Generation Bio-Tools for Accelerating Bio-Pharmaceutical Drug Discovery R&D: Technologies, Opportunities and Markets
|
|
|
|
